Two Sigma Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-152,600
| Closed | -$2.28M | – | 2852 |
|
|
2022
Q4 | $2.28M | Buy |
152,600
+136,600
| +854% | +$1.89M | 0.01% | 1172 |
|
|
2022
Q3 | $132K | Buy |
+16,000
| New | +$123K | ﹤0.01% | 2270 |
|
|
2021
Q3 | – | Sell |
-131,185
| Closed | -$865K | – | 2809 |
|
|
2021
Q2 | $865K | Sell |
131,185
-54,400
| -29% | -$375K | ﹤0.01% | 1696 |
|
|
2021
Q1 | $1.36M | Buy |
185,585
+173,100
| +1,386% | +$1.49M | ﹤0.01% | 1476 |
|
|
2020
Q4 | $72K | Buy |
+12,485
| New | +$71.5K | ﹤0.01% | 2295 |
|
|
2020
Q3 | – | Sell |
-20,085
| Closed | -$103K | – | 2746 |
|
|
2020
Q2 | $103K | Buy |
+20,085
| New | +$127K | ﹤0.01% | 2354 |
|
|
2019
Q3 | – | Sell |
-39,980
| Closed | -$269K | – | 2491 |
|
|
2019
Q2 | $269K | Sell |
39,980
-3,070
| -7% | -$26.3K | ﹤0.01% | 2049 |
|
|
2019
Q1 | $353K | Buy |
43,050
+850
| +2% | +$8.78K | ﹤0.01% | 1933 |
|
|
2018
Q4 | $675K | Buy |
42,200
+2,850
| +7% | +$62.7K | ﹤0.01% | 1655 |
|
|
2018
Q3 | $1.3M | Sell |
39,350
-270
| -0.7% | -$6.94K | ﹤0.01% | 1405 |
|
|
2018
Q2 | $895K | Buy |
39,620
+3,310
| +9% | +$78.5K | ﹤0.01% | 1657 |
|
|
2018
Q1 | $1.05M | Buy |
36,310
+7,236
| +25% | +$212K | ﹤0.01% | 1528 |
|
|
2017
Q4 | $811K | Buy |
29,074
+19,834
| +215% | +$616K | ﹤0.01% | 1596 |
|
|
2017
Q3 | $337K | Buy |
+9,240
| New | +$286K | ﹤0.01% | 1883 |
|